Becaplermin gelin the treatment of pressure ulcers : a phase II randomized, double-blind, placebo-controlled study
スポンサーリンク
概要
- 論文の詳細を見る
- 1999-05-01
著者
-
Robson Martin
Institute For Tissue Regeneration Repair And Rehabilitation
-
SMIELL Janice
The R. W. Johnson Pharmaceutical Research Institute
-
PERRY Barbara
The R. W. Johnson Pharmaceutical Research Institute
-
REES Riley
the University of Michigan Medical Center and Department of Veterans Affairs Medical Center
関連論文
- Significance of cell cycle for wound stratification in clinical trials : analysis of a pressure ulcer clinical trial utilizing cyclin D/cdk4
- Fascial fibroblast kinetic activity is increased during abdominal wall repair compared to dermal fibroblasts
- Effect of cytokine growth factors on the prevention of acute wound failure
- Dynamic forces in the cell cycle affecting fibroblasts in pressure ulcers
- Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers
- Recombinant human platelet-derived growth factor-BB (becaplermin) for healing chronic lower extremity diabetic ulcers : an open-label clinical evaluation of efficacy
- Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers : a combined analysis of four randomized studies
- Becaplermin gelin the treatment of pressure ulcers : a phase II randomized, double-blind, placebo-controlled study
- Impediments to drug development